The Harvard Drug Group recalls

The Harvard Drug Group has 79 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 1 Jul 2026. 21 are still ongoing. 11 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls79since 2015

Last 12 months11reported

Class I56% of total

Ongoing21latest 1 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 3 0 0Jan '25 5 0 2Apr 0 0 2Jul 1 2 7Oct 0 0 0Jan '26 0 1 2Apr 0 0 1Jul 0 0

Severity split

Class I 5 6%Class II 63 80%Class III 11 14%

Why the harvard drug group is recalled

Product types

Brands

By year

202645%
20251924%
202456%
202379%
202223%
202145%
2020911%
20172633%
201611%
201523%

Ongoing the harvard drug group recalls

21 active

Reported	Class	Recall	Company	Reason	Where
1 Jul 2026Drug	CLASS II	Carton Label: Major, Methylergonovine Maleate Tablets recalledMethylergonovine Maleate	The Harvard Drug Group	Potency & Assay	Nationwide
29 Apr 2026Drug	CLASS II	Omega-3-Acid, Ethyl Esters, Capsules recalled by The Harvard Drug GroupOmega-3-acid Ethyl Esters	The Harvard Drug Group	Potency & Assay	Nationwide
22 Apr 2026Drug	CLASS II	Memantine Hydrochloride Extended-Release, Capsules, 7 mg recalledMemantine Hydrochloride	The Harvard Drug Group	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Midodrine Hydrochloride Tablets, USP, 5 mg ( blister packs) recalledMidodrine Hydrochloride	The Harvard Drug Group	Packaging Defects	Nationwide
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister packs) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister pack) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide

All the harvard drug group recalls, newest first

79 total

Reported	Class	Recall	Company	Reason	Where
1 Jul 2026Drug	CLASS II	Carton Label: Major, Methylergonovine Maleate Tablets recalledMethylergonovine Maleate	The Harvard Drug Group	Potency & Assay	Nationwide
29 Apr 2026Drug	CLASS II	Omega-3-Acid, Ethyl Esters, Capsules recalled by The Harvard Drug GroupOmega-3-acid Ethyl Esters	The Harvard Drug Group	Potency & Assay	Nationwide
22 Apr 2026Drug	CLASS II	Memantine Hydrochloride Extended-Release, Capsules, 7 mg recalledMemantine Hydrochloride	The Harvard Drug Group	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Midodrine Hydrochloride Tablets, USP, 5 mg ( blister packs) recalledMidodrine Hydrochloride	The Harvard Drug Group	Packaging Defects	Nationwide
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister packs) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister pack) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
15 Oct 2025Drug	CLASS II	Major ChlorproMAZINE Hydrochloride Tablets recalled	The Harvard Drug Group	Nitrosamine Impurity	Nationwide
15 Oct 2025Drug	CLASS II	Major ChlorproMAZINE Hydrochloride Tablets recalled	The Harvard Drug Group	Nitrosamine Impurity	Nationwide
15 Oct 2025Drug	CLASS II	Major ChlorproMAZINE Hydrochloride Tablets recalled	The Harvard Drug Group	Nitrosamine Impurity	Nationwide
15 Oct 2025Drug	CLASS II	Major ChlorproMAZINE Hydrochloride Tablets, USP, 50 mg recalled	The Harvard Drug Group	Nitrosamine Impurity	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.